Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joaquin Gabriel Reinoso Toledo"'
Autor:
Robert I. Haddad, Kevin Harrington, Makoto Tahara, Robert L. Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabil F. Saba, Milena Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Angel Alvarez Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller-Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Li Wei, Athanassios Argiris
Publikováno v:
Journal of Clinical Oncology. 41:2166-2180
PURPOSE CheckMate 651 (ClinicalTrials.gov identifier: NCT02741570 ) evaluated first-line nivolumab plus ipilimumab versus EXTREME (cetuximab plus cisplatin/carboplatin plus fluorouracil ≤ six cycles, then cetuximab maintenance) in recurrent/metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea41d080266110a8825a284e080af38
https://doi.org/10.1200/jco.22.00332
https://doi.org/10.1200/jco.22.00332
Autor:
Salvador Macias-Diaz, Ana Lilia Castruita Avila, Joaquin Gabriel Reinoso Toledo, Mario Garcia Carrasco
Publikováno v:
Clinical Oncology and Research. :1-4
Background: Vitamin D deficiency has been associated with not achieving a complete pathological response in patients with breast cancer after neoadjuvant chemotherapy. The objective of this study was to determine whether vitamin D deficiency is assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b1dd2ecbad6f9d8111f8b7eed383241
https://doi.org/10.31487/j.cor.2020.10.04
https://doi.org/10.31487/j.cor.2020.10.04